The DOI matches its Crossref record; 265 of the 265 references it cites were found in a registry or an index.
Multiple Myeloma: Increasing Evidence for a Multistep Transformation Process
Open accessAbstract
Multiple Myeloma (Mm) is a clonal B-cell neoplasm that affects terminally differentiated B cells (ie, plasma cells) and may proceed through different phases: an inactive phase in which tumor cells are nonproliferating mature plasma cells, an active phase with a small percentage (<1%) of proliferating plasmablastic cells, and a fulminant phase with the frequent occurrence of extramedullary proliferation and an increase in plasmablastic cells. During the past years, considerable progress has been made in identifying some of the critical components of neoplastic transformation in MM. This review intends to propose a model of a stepwise malignant transformation during MM pathogenesis. Both diagnostic and therapeutic implications of this model will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression
Herrmann, F., Andreeff, M., Gruss, H., Brach, M., Lübbert, M., & Mertelsmann, R. H. (1991) · Blood · doi:10.1182/blood.v78.8.2070.bloodjournal7882070 · Cited by 63
RetractedDarnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Signal transduction by receptors with tyrosine kinase activity
Ullrich, A., & Schlessinger, J. (1990) · Cell · doi:10.1016/0092-8674(90)90801-k · Cited by 5,435
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Barbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
Kishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.1 · Cited by 2,069
cPLA2 is phosphorylated and activated by MAP kinase
Lin, L.-L., Wartmann, M., Lin, A. Y., Knopf, J. L., Seth, A., & Davis, R. J. (1993) · Cell · doi:10.1016/0092-8674(93)90666-e · Cited by 1,849
Weinberg, R. A. (1991) · Science · doi:10.1126/science.1659741 · Cited by 1,756
The Human Hematopoietic Colony-Stimulating Factors
Clark, S. C., & Kamen, R. (1987) · Science · doi:10.1126/science.3296190 · Cited by 1,639
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
Kawano, M., Hirano, T., Matsuda, T., Taga, T., Horii, Y., Iwato, K., Asaoku, H., Tang, B., Tanabe, O., Tanaka, H., et al. (1988) · Nature · doi:10.1038/332083a0 · Cited by 1,633
The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling
Lowenstein, E. J., Daly, R. J., Batzer, A. G., Li, W., Margolis, B., Lammers, R., Ullrich, A., Skolnik, E. Y., Bar-Sagi, D., & Schlessinger, J. (1992) · Cell · doi:10.1016/0092-8674(92)90167-b · Cited by 1,631
Interleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
STATs: Signal Transducers and Activators of Transcription
Ihle, J. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81277-5 · Cited by 1,381
Molecular thanatopsis: a discourse on the BCL2 family and cell death
Yang, E., & Korsmeyer, S. (1996) · Blood · doi:10.1182/blood.v88.2.386.bloodjournal882386 · Cited by 1,332
Shiang, R., Thompson, L. M., Zhu, Y.-Z., Church, D. M., Fielder, T. J., Bocian, M., Winokur, S. T., & Wasmuth, J. J. (1994) · Cell · doi:10.1016/0092-8674(94)90302-6 · Cited by 1,329
Kishimoto, T., Taga, T., & Akira, S. (1994) · Cell · doi:10.1016/0092-8674(94)90333-6 · Cited by 1,328
A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction
Pelicci, G., Lanfrancone, L., Grignani, F., McGlade, J., Cavallo, F., Forni, G., Nicoletti, I., Grignani, F., Pawson, T., & Giuseppe Pelicci, P. (1992) · Cell · doi:10.1016/0092-8674(92)90536-l · Cited by 1,326
Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF)
Akira, S., Hirano, T., Taga, T., & Kishimoto, T. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.11.2199284 · Cited by 1,306
Souza, L., Boone, T., Gabrilove, J., Lai, P., Zsebo, K., Murdock, D., Chazin, V., Bruszewski, J., Lu, H., Chen, K., et al. (1986) · Science · doi:10.1126/science.232.4746.61 · Cited by 1,266
The CD40 Antigen and Its Ligand
Banchereau, J., Bazan, F., Blanchard, D., Brière, F., Galizzi, J., van Kooten, C., Liu, Y. J., Rousset, F., & Saeland, S. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.881 · Cited by 1,263
Signal transduction via the MAP kinases: proceed at your own RSK.
Blenis, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.5889 · Cited by 1,243
Egan, S. E., Giddings, B. W., Brooks, M. W., Buday, L., Sizeland, A. M., & Weinberg, R. A. (1993) · Nature · doi:10.1038/363045a0 · Cited by 1,215
Bcl-2 initiates a new category of oncogenes: regulators of cell death
Korsmeyer, S. (1992) · Blood · doi:10.1182/blood.v80.4.879.879 · Cited by 1,122
Buday, L., & Downward, J. (1993) · Cell · doi:10.1016/0092-8674(93)90146-h · Cited by 1,079
The MAP kinase cascade is essential for diverse signal transduction pathways
Nishida, E., & Gotoh, Y. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90019-j · Cited by 1,076
Biological and clinical aspects of interleukin 6
Hirano, T., Akira, S., Taga, T., & Kishimoto, T. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90173-7 · Cited by 1,066
Metcalf, D. (1989) · Nature · doi:10.1038/339027a0 · Cited by 1,023
The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1
Rozakis-Adcock, M., Fernley, R., Wade, J., Pawson, T., & Bowtell, D. (1993) · Nature · doi:10.1038/363083a0 · Cited by 1,009
Association and Activation of Jak-Tyk Kinases by CNTF-LIF-OSM-IL-6 β Receptor Components
Stahl, N., Boulton, T. G., Farruggella, T., Ip, N. Y., Davis, S., Witthuhn, B. A., Quelle, F. W., Silvennoinen, O., Barbieri, G., Pellegrini, S., et al. (1994) · Science · doi:10.1126/science.8272873 · Cited by 979
Rozakis-Adcock, M., McGlade, J., Mbamalu, G., Pelicci, G., Daly, R., Li, W., Batzer, A., Thomas, S., Brugge, J., Pelicci, P. G., et al. (1992) · Nature · doi:10.1038/360689a0 · Cited by 973
Li, N., Batzer, A., Daly, R., Yajnik, V., Skolnik, E., Chardin, P., Bar-Sagi, D., Margolis, B., & Schlessinger, J. (1993) · Nature · doi:10.1038/363085a0 · Cited by 952
Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia
Rousseau, F., Bonaventure, J., Legeai-Mallet, L., Pelet, A., Rozet, J.-M., Maroteaux, P., Merrer, M. L., & Munnich, A. (1994) · Nature · doi:10.1038/371252a0 · Cited by 928
Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
Schindler, C., Shuai, K., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1496401 · Cited by 899
DeCaprio, J. A., Ludlow, J. W., Lynch, D., Furukawa, Y., Griffin, J., Piwnica-Worms, H., Huang, C.-M., & Livingston, D. M. (1989) · Cell · doi:10.1016/0092-8674(89)90507-2 · Cited by 897
Lütticken, C., Wegenka, U. M., Yuan, J., Buschmann, J., Schindler, C., Ziemiecki, A., Harpur, A. G., Wilks, A. F., Yasukawa, K., Taga, T., et al. (1994) · Science · doi:10.1126/science.8272872 · Cited by 814
Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor
Nagata, S., Tsuchiya, M., Asano, S., Kaziro, Y., Yamazaki, T., Yamamoto, O., Hirata, Y., Kubota, N., Oheda, M., Nomura, H., et al. (1986) · Nature · doi:10.1038/319415a0 · Cited by 812
Human Sos1: a Guanine Nucleotide Exchange Factor for Ras that Binds to GRB2
Chardin, P., Camonis, J. H., Gale, N. W., van Aelst, L., Schlessinger, J., Wigler, M. H., & Bar-Sagi, D. (1993) · Science · doi:10.1126/science.8493579 · Cited by 797
Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 779
Activation of Transcription by IFN-γ: Tyrosine Phosphorylation of a 91-kD DNA Binding Protein
Shuai, K., Schindler, C., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1281555 · Cited by 775
Klein, B., Zhang, X., Jourdan, M., Content, J., Houssiau, F., Aarden, L., Piechaczyk, M., & Bataille, R. (1989) · Blood · doi:10.1182/blood.v73.2.517.517 · Cited by 763
IL-6-Induced Homodimerization of gp130 and Associated Activation of a Tyrosine Kinase
Murakami, M., Hibi, M., Nakagawa, N., Nakagawa, T., Yasukawa, K., Yamanishi, K., Taga, T., & Kishimoto, T. (1993) · Science · doi:10.1126/science.8511589 · Cited by 724
Signaling by the cytokine receptor superfamily: JAKs and STATs
Ihle, J. N., Witthuhn, B. A., Quelle, F. W., Yamamoto, K., Thierfelder, W. E., Kreider, B., & Silvennoinen, O. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90026-4 · Cited by 651
Korsmeyer, S. J. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89010-1 · Cited by 648
Schindler, C., Fu, X. Y., Improta, T., Aebersold, R., & Darnell, J. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7836 · Cited by 647
Chesi, M., Nardini, E., Brents, L. A., Schröck, E., Ried, T., Kuehl, W. M., & Bergsagel, P. L. (1997) · Nature Genetics · doi:10.1038/ng0797-260 · Cited by 637
Self-citationThe Function of GRB2 in Linking the Insulin Receptor to Ras Signaling Pathways
Skolnik, E. Y., Batzer, A., Li, N., Lee, C.-H., Lowenstein, E., Mohammadi, M., Margolis, B., & Schlessinger, J. (1993) · Science · doi:10.1126/science.8316835 · Cited by 632
Cytokine Receptors and Signal Transduction
Miyajima, A., Kitamura, T., Harada, N., Yokota, T., & Arai, K.-I. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.001455 · Cited by 605
Tavormina, P. L., Shiang, R., Thompson, L. M., Zhu, Y.-Z., Wilkin, D. J., Lachman, R. S., Wilcox, W. R., Rimoin, D. L., Cohn, D. H., & Wasmuth, J. J. (1995) · Nature Genetics · doi:10.1038/ng0395-321 · Cited by 601
Requirement for the Transcription Factor LSIRF/IRF4 for Mature B and T Lymphocyte Function
Mittrücker, H.-W., Matsuyama, T., Grossman, A., Kündig, T. M., Potter, J., Shahinian, A., Wakeham, A., Patterson, B., Ohashi, P. S., & Mak, T. W. (1997) · Science · doi:10.1126/science.275.5299.540 · Cited by 583
Nakajima, T., Kinoshita, S., Sasagawa, T., Sasaki, K., Naruto, M., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2207 · Cited by 578
Chauhan, D., Uchiyama, H., Akbarali, Y., Urashima, M., Yamamoto, K., Libermann, T., & Anderson, K. (1996) · Blood · doi:10.1182/blood.v87.3.1104.bloodjournal8731104 · Cited by 563
Self-citationFu, X. Y., Schindler, C., Improta, T., Aebersold, R., & Darnell, J. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7840 · Cited by 533
Interleukin-6 in human multiple myeloma
Klein, B., Zhang, X., Lu, Z., & Bataille, R. (1995) · Blood · doi:10.1182/blood.v85.4.863.bloodjournal854863 · Cited by 520
Purification and characterization of the Fas-ligand that induces apoptosis.
Suda, T., & Nagata, S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.873 · Cited by 507
Naski, M. C., Wang, Q., Xu, J., & Ornitz, D. M. (1996) · Nature Genetics · doi:10.1038/ng0696-233 · Cited by 498
Bataille, R., Jourdan, M., Zhang, X. G., & Klein, B. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114392 · Cited by 479
A new cytokine receptor superfamily
Cosman, D., Lyman, S. D., Idzerda, R. L., Beckmann, M. P., Park, L. S., Goodwin, R. G., & March, C. J. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90051-c · Cited by 476
Genetic determinants of p53-induced apoptosis and growth arrest.
Polyak, K., Waldman, T., He, T. C., Kinzler, K. W., & Vogelstein, B. (1996) · Genes & Development · doi:10.1101/gad.10.15.1945 · Cited by 459
Rettig, M. B., Ma, H. J., Vescio, R. A., Põld, M., Schiller, G., Belson, D., Savage, A., Nishikubo, C., Wu, C., Fraser, J., et al. (1997) · Science · doi:10.1126/science.276.5320.1851 · Cited by 458
Hermine, O., Haioun, C., Lepage, E., d'Agay, M., Briere, J., Lavignac, C., Fillet, G., Salles, G., Marolleau, J., Diebold, J., et al. (1996) · Blood · doi:10.1182/blood.v87.1.265.265 · Cited by 452
Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway.
Puil, L., Liu, J., Gish, G., Mbamalu, G., Bowtell, D., Pelicci, P. G., Arlinghaus, R., & Pawson, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06319.x · Cited by 438
Uchiyama, H., Barut, B., Mohrbacher, A., Chauhan, D., & Anderson, K. (1993) · Blood · doi:10.1182/blood.v82.12.3712.3712 · Cited by 418
Self-citationMurine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
Klein, B., Wijdenes, J., Zhang, X., Jourdan, M., Boiron, J., Brochier, J., Liautard, J., Merlin, M., Clement, C., & Morel-Fournier, B. (1991) · Blood · doi:10.1182/blood.v78.5.1198.1198 · Cited by 418
vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells.
Katzav, S., Martin‐Zanca, D., & Barbacid, M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08354.x · Cited by 410
Bradbury, L. E., Kansas, G. S., Levy, S., Evans, R. L., & Tedder, T. F. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.9.2841 · Cited by 402
Dewald, G., Kyle, R., Hicks, G., & Greipp, P. (1985) · Blood · doi:10.1182/blood.v66.2.380.380 · Cited by 401
HEMOPOIETIC CELL GROWTH FACTORS AND THEIR RECEPTORS
Nicola, N. A. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.000401 · Cited by 400
IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade
Ogata, A., Chauhan, D., Teoh, G., Treon, S. P., Urashima, M., Schlossman, R. L., & Anderson, K. C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.5.2212 · Cited by 399
Self-citationTricot, G., Barlogie, B., Jagannath, S., Bracy, D., Mattox, S., Vesole, D., Naucke, S., & Sawyer, Jr. (1995) · Blood · doi:10.1182/blood.v86.11.4250.bloodjournal86114250 · Cited by 395
Meyers, G. A., Orlow, S. J., Munro, I. R., Przylepa, K. A., & Jabs, E. W. (1995) · Nature Genetics · doi:10.1038/ng1295-462 · Cited by 390
Bataille, R., & Harousseau, J.-L. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706053362307 · Cited by 389
Mandelli, F., Avvisati, G., Amadori, S., Boccadoro, M., Gernone, A., Lauta, V. M., Marmont, F., Petrucci, M. T., Tribalto, M., Vegna, M. L., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005173222005 · Cited by 382
How receptor tyrosine kinases activate ras
Schlessinger, J. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90031-h · Cited by 379
The role of CD40 in the regulation of humoral and cell-mediated immunity
Durie, F. H., Foy, T. M., Masters, S. R., Laman, J. D., & Noelle, R. J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90269-0 · Cited by 373
Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma
Bergsagel, P. L., Chesi, M., Nardini, E., Brents, L. A., Kirby, S. L., & Kuehl, W. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13931 · Cited by 367
Self-citationAmati, B., & Land, H. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90098-1 · Cited by 362
Boulton, T. G., Stahl, N., & Yancopoulos, G. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78174-5 · Cited by 361
Phenotypic difference of normal plasma cells from mature myeloma cells
Harada, H., Kawano, M., Huang, N., Harada, Y., Iwato, K., Tanabe, O., Tanaka, H., Sakai, A., Asaoku, H., & Kuramoto, A. (1993) · Blood · doi:10.1182/blood.v81.10.2658.2658 · Cited by 355
Cytogenetic findings in 200 patients with multiple myeloma
Sawyer, J. R., Waldron, J. A., Jagannath, S., & Barlogie, B. (1995) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(94)00284-i · Cited by 343
Apoptosis Meets Signal Transduction: Elimination of a BAD Influence
Gajewski, T. F., & Thompson, C. B. (1996) · Cell · doi:10.1016/s0092-8674(00)81377-x · Cited by 341
Fas and Fas Ligand: A Death Factor and Its Receptor
Nagata, S. (1994) · Advances in Immunology · doi:10.1016/s0065-2776(08)60672-0 · Cited by 338
CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation
Noelle, R. J., Ledbetter, J. A., & Aruffo, A. A. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90068-i · Cited by 324
Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor
Lust, J. A., Donovan, K. A., Kline, M. P., Greipp, P. R., Kyle, R. A., & Maihle, N. J. (1992) · Cytokine · doi:10.1016/1043-4666(92)90043-q · Cited by 316
Bakkus, M., Heirman, C., Van Riet, I., Van Camp, B., & Thielemans, K. (1992) · Blood · doi:10.1182/blood.v80.9.2326.2326 · Cited by 314
Li, L. H., Nerlov, C., Prendergast, G., MacGregor, D., & Ziff, E. B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06724.x · Cited by 311
Gerhartz, C., Heesel, B., Sasse, J., Hemmann, U., Landgraf, C., Schneider-Mergener, J., Horn, F., Heinrich, P. C., & Graeve, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12991 · Cited by 307
Regulators and Effectors of ras Proteins
Bollag, G., & McCormick, F. (1991) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.07.110191.003125 · Cited by 300
Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130.
Narazaki, M., Witthuhn, B. A., Yoshida, K., Silvennoinen, O., Yasukawa, K., Ihle, J. N., Kishimoto, T., & Taga, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2285 · Cited by 299
Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates
Bustelo, X. R., Ledbetter, J. A., & Barbacid, M. (1992) · Nature · doi:10.1038/356068a0 · Cited by 296
Binding of the Ras Activator Son of Sevenless to Insulin Receptor Substrate-1 Signaling Complexes
Baltensperger, K., Kozma, L. M., Cherniack, A. D., Klarlund, J. K., Chawla, A., Banerjee, U., & Czech, M. P. (1993) · Science · doi:10.1126/science.8391166 · Cited by 290
Ye, B. H., Chaganti, S., Chang, C. C., Niu, H., Corradini, P., Chaganti, R. S., & Dalla-Favera, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00311.x · Cited by 277
Chesi, M., Bergsagel, P., Brents, L., Smith, C., Gerhard, D., & Kuehl, W. (1996) · Blood · doi:10.1182/blood.v88.2.674.bloodjournal882674 · Cited by 277
Zhang, X., Gaillard, J., Robillard, N., Lu, Z., Gu, Z., Jourdan, M., Boiron, J., Bataille, R., & Klein, B. (1994) · Blood · doi:10.1182/blood.v83.12.3654.3654 · Cited by 276
Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth.
Sato, K., Tsuchiya, M., Saldanha, J. W., Koishihara, Y., Ohsugi, Y., Kishimoto, T., & Bendig, M. M. (1993) · PubMed · Cited by 274
Chauhan, D., Kharbanda, S., Ogata, A., Urashima, M., Teoh, G., Robertson, M., Kufe, D. W., & Anderson, K. C. (1997) · Blood · doi:10.1182/blood.v89.1.227 · Cited by 272
Self-citationInterleukin-6 Inhibits Apoptosis of Malignant Plasma Cells
Lichtenstein, A., Tu, Y., Fady, C., Vescio, R., & Berenson, J. (1995) · Cellular Immunology · doi:10.1006/cimm.1995.1076 · Cited by 271
Shc proteins are phosphorylated and regulated by the v-Src and v-Fps protein-tyrosine kinases.
McGlade, J., Cheng, A., Pelicci, G., Pelicci, P. G., & Pawson, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.8869 · Cited by 264
Cytokine receptors and signal transduction
Taga, T., & Kishimoto, T. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.15.1334470 · Cited by 263
Interleukin-6 prevents dexamethasone-induced myeloma cell death
Hardin, J., MacLeod, S., Grigorieva, I., Chang, R., Barlogie, B., Xiao, H., & Epstein, J. (1994) · Blood · doi:10.1182/blood.v84.9.3063.3063 · Cited by 262
Terstappen, L., Johnsen, S., Segers-Nolten, I., & Loken, M. (1990) · Blood · doi:10.1182/blood.v76.9.1739.1739 · Cited by 259
Chromosomal Translocations In Lymphoid Malignancies Reveal Novel Proto-Oncogenes
Korsmeyer, S. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.785 · Cited by 258
Bataille, R., Chappard, D., Marcelli, C., Dessauw, P., Baldet, P., Sany, J., & Alexandre, C. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115305 · Cited by 253
Cytokine Receptors and Signal Transduction
Miyajima, A. (1997) · Proceedings of Annual Meeting of JSIR · doi:10.14847/jsirib1987.11.3 · Cited by 251
Hemmann, U., Gerhartz, C., Heesel, B., Sasse, J., Kurapkat, G., Grötzinger, J., Wollmer, A., Zhong, Z., Darnell, J. E., Graeve, L., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12999 · Cited by 239
Buday, L., Egan, S. E., Rodriguez Viciana, P., Cantrell, D. A., & Downward, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37070-9 · Cited by 238
Attardi, L. D., Lowe, S. W., Brugarolas, J., & Jacks, T. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00739.x · Cited by 238
Transforming growth factor-beta1: differential effects on multiple myeloma versus normal B cells
Urashima, M., Ogata, A., Chauhan, D., Hatziyanni, M., Vidriales, M., Dedera, D., Schlossman, R., & Anderson, K. (1996) · Blood · doi:10.1182/blood.v87.5.1928.1928 · Cited by 235
Self-citation'Role of bone marrow stromal cells in the growth of human multiple myeloma
Caligaris-Cappio, F., Bergui, L., Gregoretti, M., Gaidano, G., Gaboli, M., Schena, M., Zallone, A., & Marchisio, P. (1991) · Blood · doi:10.1182/blood.v77.12.2688.2688 · Cited by 234
Motokura, T., & Arnold, A. (1993) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(05)80334-x · Cited by 232
Zhang, X. G., Gu, J. J., Lu, Z. Y., Yasukawa, K., Yancopoulos, G. D., Turner, K., Shoyab, M., Taga, T., Kishimoto, T., & Bataille, R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1337 · Cited by 230
Cutler, R. L., Liu, L., Damen, J. E., & Krystal, G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80558-4 · Cited by 229
Lai, J., Zandecki, M., Mary, J., Bernardi, F., Izydorczyk, V, Flactif, M., Morel, P., Jouet, J., Bauters, F., & Facon, T. (1995) · Blood · doi:10.1182/blood.v85.9.2490.bloodjournal8592490 · Cited by 216
Liu, P., Leong, T., Quam, L., Billadeau, D., Kay, N., Greipp, P., Kyle, R., Oken, M., & Van Ness, B. (1996) · Blood · doi:10.1182/blood.v88.7.2699.bloodjournal8872699 · Cited by 215
Hepatocyte growth factor and its receptor c-met in multiple myeloma
Borset, M., Hjorth-Hansen, H., Seidel, C., Sundan, A., & Waage, A. (1996) · Blood · doi:10.1182/blood.v88.10.3998.bloodjournal88103998 · Cited by 209
Williams, M., Meeker, T., & Swerdlow, S. (1991) · Blood · doi:10.1182/blood.v78.2.493.493 · Cited by 202
p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy
Neri, A., Baldini, L., Trecca, D., Cro, L., Polli, E., & Maiolo, A. (1993) · Blood · doi:10.1182/blood.v81.1.128.128 · Cited by 199
Gaillard, J., Bataille, R., Brailly, H., Zuber, C., Yasukawa, K., Attal, M., Maruo, N., Taga, T., Kishimoto, T., & Klein, B. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230408 · Cited by 196
Damen, J., Liu, L., Cutler, R., & Krystal, G. (1993) · Blood · doi:10.1182/blood.v82.8.2296.2296 · Cited by 193
Schwarze, M. M., & Hawley, R. G. (1995) · PubMed · Cited by 189
The effector interactions of p21ras
Marshall, M. S. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90175-m · Cited by 189
Tyrosine Phosphorylation of the vav Proto-Oncogene Product in Activated B Cells
Bustelo, X. R., & Barbacid, M. (1992) · Science · doi:10.1126/science.256.5060.1196 · Cited by 188
Seto, M., Yamamoto, K., Iida, S., Akao, Y., Utsumi, K. R., Kubonishi, I., Miyoshi, I., Ohtsuki, T., Yawata, Y., & Namba, M. (1992) · PubMed · Cited by 187
Frequent Hypermethylation of p16 and p15 Genes in Multiple Myeloma
Ng, M. H. L., Chung, Y. F., Lo, K. W., Wickham, N. W. R., Lee, J. C. K., & Huang, D. P. (1997) · Blood · doi:10.1182/blood.v89.7.2500 · Cited by 187
Potter, M., & Wiener, F. (1992) · Carcinogenesis · doi:10.1093/carcin/13.10.1681 · Cited by 181
CD40 ligand triggered interleukin-6 secretion in multiple myeloma
Urashima, M., Chauhan, D., Uchiyama, H., Freeman, G., & Anderson, K. (1995) · Blood · doi:10.1182/blood.v85.7.1903.bloodjournal8571903 · Cited by 181
Self-citationInsulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines
Georgii-Hemming, P., Wiklund, H., Ljunggren, O., & Nilsson, K. (1996) · Blood · doi:10.1182/blood.v88.6.2250.bloodjournal8862250 · Cited by 177
Nakafuku, M., Satoh, T., & Kaziro, Y. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41796-6 · Cited by 176
Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1)
Rousseau, F. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.4.509 · Cited by 173
Inhibitors of ras farnesyltransferases
Tamanoi, F. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90072-u · Cited by 170
Ras oncogene mutation in multiple myeloma.
Neri, A., Murphy, J. P., Cro, L., Ferrero, D., Tarella, C., Baldini, L., & Dalla-Favera, R. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.5.1715 · Cited by 164
Identification and Characterization of a New Mammalian Mitogen-Activated Protein Kinase Kinase, MKK2
Wu, J., Harrison, J. K., Dent, P., Lynch, K. R., Weber, M. J., & Sturgill, T. W. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4539 · Cited by 161
Ernst, M., Gearing, D. P., & Dunn, A. R. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06420.x · Cited by 160
The Development of a Model for the Homing of Multiple Myeloma Cells to Human Bone Marrow
Urashima, M., Chen, B. P., Chen, S., Pinkus, G. S., Bronson, R. T., Dedera, D. A., Hoshi, Y., Teoh, G., Ogata, A., Treon, S. P., et al. (1997) · Blood · doi:10.1182/blood.v90.2.754 · Cited by 159
Self-citationErnst, M., Oates, A. C., & Dunn, A. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.30136 · Cited by 152
Matsuguchi, T., Salgia, R., Hallek, M. J., Eder, M., Druker, B. J., Ernst, T. J., & Griffin, J. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37647-0 · Cited by 149
Self-citationErks: their fifteen minutes has arrived.
Crews, C. M., Alessandrini, A., & Erikson, R. L. (1992) · PubMed · Cited by 148
Weinberg, R. A. (1993) · Neuron · doi:10.1016/0896-6273(93)90177-s · Cited by 147
Interleukin-6 Signals Activating junB and TIS11 Gene Transcription in a B-Cell Hybridoma
Nakajima, K., & Wall, R. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.3.1409 · Cited by 147
p53 and RAS gene mutations in multiple myeloma.
Portier, M., Molès, J., Mazars, G. R., Jeanteur, P., Bataille, R., Klein, B., & Theillet, C. G. (1992) · PubMed · Cited by 145
Cytokine Network in Human Multiple Myeloma
Klein, B., & Bataille, R. (1992) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30344-7 · Cited by 145
Interleukin-6 in clinical medicine
Bauer, J., & Herrmann, F. (1991) · Annals of Hematology · doi:10.1007/bf01729833 · Cited by 139
Matsuguchi, T., Inhorn, R. C., Carlesso, N., Xu, G., Druker, B. J., & Griffin, J. D. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb06999.x · Cited by 139
Nachbaur, D., Herold, M., Maneschg, A., & Huber, H. P. (1991) · Annals of Hematology · doi:10.1007/bf01714900 · Cited by 135
Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells
Pettersson, M., Jernberg‐Wiklund, H., Larsson, L., Sundström, C., Givol, I., Tsujimoto, Y., & Nilsson, K. (1992) · Blood · doi:10.1182/blood.v79.2.495.495 · Cited by 134
A common FGFR3 gene mutation in hypochondroplasia
Prinos, P., Costa, T., Sommer, A., et al. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.11.2097 · Cited by 134
Vescio, R. A., Cao, J., Hong, C. H., Lee, J. C., Wu, C. H., DerDanielian, M., Wu, V., Newman, R., Lichtenstein, A. K., & Berenson, J. R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.5.2487 · Cited by 133
Monoclonal Circulating B Cells in Multiple Myeloma
Pilarski, L. M., & Jensen, G. S. (1992) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30346-0 · Cited by 132
Børset, M., Lien, E., Espevik, T., Helseth, E., Waage, A., & Sundan, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24655 · Cited by 131
Tauchi, T., Boswell, H. S., Leibowitz, D. S., & Broxmeyer, H. E. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.1.167 · Cited by 129
Savino, R., Lahm, A., Salvati, A. L., Ciapponi, L., Sporeno, E., Altamura, S., Paonessa, G., Toniatti, C., & Ciliberto, G. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06389.x · Cited by 128
Shima, Y., Nishimoto, N., Ogata, A., Fujii, Y., Yoshizaki, K., & Kishimoto, T. (1995) · Blood · doi:10.1182/blood.v85.3.757.bloodjournal853757 · Cited by 128
Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma.
Williams, M. E., Swerdlow, S. H., Rosenberg, C. L., & Arnold, A. (1993) · PubMed · Cited by 127
Lioubin, M. N., Myles, G. M., Carlberg, K., Bowtell, D. D. L., & Rohrschneider, L. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.5682-5691.1994 · Cited by 126
Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias
Corradini, P., Ladetto, M., Voena, C., Palumbo, A. P., Inghirami, G., Knowles, D., Boccadoro, M., & Pileri, A. (1993) · Blood · doi:10.1182/blood.v81.10.2708.2708 · Cited by 122
Zhang, X., Bataille, R., Jourdan, M., Saeland, S., Banchereau, J., Mannoni, P., & Klein, B. (1990) · Blood · doi:10.1182/blood.v76.12.2599.2599 · Cited by 119
Differential shedding of the two subunits of the interleukin‐6 receptor
Müllberg, J., Dittrich, E., Graeve, L., Gerhartz, C., Yasukawa, K., Taga, T., Kishimoto, T., Heinrich, P. C., & Rose‐John, S. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80507-q · Cited by 118
Gu, Z., Costes, V., Lu, Z., Zhang, X., Pitard, V., Moreau, J., Bataille, R., Wijdenes, J., Rossi, J., & Klein, B. (1996) · Blood · doi:10.1182/blood.v88.10.3972.bloodjournal88103972 · Cited by 116
The Cellular Effects of E2F Overexpression
Adams, P. D., & Kaelin, W. G. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-79910-5_4 · Cited by 113
Freund, G. G., Kulas, D. T., & Mooney, R. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.4.1811 · Cited by 111
Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein
Urashima, M., Ogata, A., Chauhan, D., Vídriales, M., Teoh, G., Hoshi, Y., Schlossman, R., DeCaprio, J. A., & Anderson, K. C. (1996) · Blood · doi:10.1182/blood.v88.6.2219.bloodjournal8862219 · Cited by 107
Self-citationMDM2 Protein Overexpression Promotes Proliferation and Survival of Multiple Myeloma Cells
Teoh, G., Urashima, M., Ogata, A., Chauhan, D., DeCaprio, J. A., Treon, S. P., Schlossman, R. L., & Anderson, K. C. (1997) · Blood · doi:10.1182/blood.v90.5.1982 · Cited by 106
Self-citationThe Jak–STAT pathway: specific signal transduction from the cell membrane to the nucleus
Heim, M. H. (1996) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1996.103248.x · Cited by 106
Szczepek, A. J., Bergsagel, P. L., Axelsson, L., Brown, C. B., Belch, A. R., & Pilarski, L. M. (1997) · Blood · doi:10.1182/blood.v89.5.1824 · Cited by 105
Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma
Selvanayagam, P., Blick, M. B., Narni, F., van Tuinen, P., Ledbetter, D., Alexanian, R., Saunders, G., & Barlogie, B. (1988) · Blood · doi:10.1182/blood.v71.1.30.30 · Cited by 105
Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias.
Corradini, P., Inghirami, G., Astolfi, M., Ladetto, M., Voena, C., Ballerini, P. F., Gu, W. J., Nilsson, K., Knowles, D. M., II, & Boccadoro, M. (1994) · PubMed · Cited by 103
A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene
Komatsu, H., Iida, S., Yamamoto, K., Mikuni, C., Nitta, M., Takahashi, T., Ueda, R., & Seto, M. (1994) · Blood · doi:10.1182/blood.v84.4.1226.1226 · Cited by 100
Welham, M. J., Duronio, V., Leslie, K. B., Bowtell, D. D. L., & Schrader, J. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31944-0 · Cited by 100
Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells
Lu, Z., Zhang, X., Rodríguez, C., Wijdenes, J., Gu, Z., Morel-Fournier, B., Harousseau, J., Bataille, R., Rossi, J., & Klein, B. (1995) · Blood · doi:10.1182/blood.v85.9.2521.bloodjournal8592521 · Cited by 100
Yin, T., & Yang, Y. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41921-1 · Cited by 99
Raynaud, S., Bekri, S., Leroux, D., Grosgeorge, J., Klein, B., Bastard, C., Gaudray, P., & Simon, M. (1993) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870080204 · Cited by 99
Mutations of the p53 gene in human myeloma cell lines.
Mazars, G. R., Portier, M., Zhang, X. G., et al. (1992) · PubMed · Cited by 97
IFN-alpha induces autocrine production of IL-6 in myeloma cell lines
Jourdan, M., Zhang, X., Portier, M., Boiron, J.-M., Bataille, R., & Klein, B. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.12.4402 · Cited by 96
Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma.
Klein, B. (1995) · PubMed · Cited by 95
Anti‐human interleukin‐6 receptor antibody inhibits human myeloma growth in vivo
Suzuki, H., Yasukawa, K., Saito, T., Goitsuka, R., Hasegawa, A., Ohsugi, Y., Taga, T., & Kishimoto, T. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220806 · Cited by 94
Westin, J., Rödjer, S., Turesson, I., Cortelezzi, A., Hjorth, M., Zador, G., & for a Cooperative Study Group (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb08364.x · Cited by 92
Billadeau, D. D., Jelinek, D. F., Shah, N., LeBien, T. W., & Ness, B. V. (1995) · PubMed · Cited by 92
Aman, M., Rudolf, G., Goldschmitt, J., Aulitzky, W. E., Lam, C., Huber, C. G., & Peschel, C. (1993) · Blood · doi:10.1182/blood.v82.8.2371.2371 · Cited by 90
Sporeno, E., Savino, R., Ciapponi, L., Paonessa, G., Cabibbo, A., Lahm, A., Pulkki, K. J., Sun, R., Toniatti, C., Klein, B., et al. (1996) · Blood · doi:10.1182/blood.v87.11.4510.bloodjournal87114510 · Cited by 90
Interleukin-2-induced tyrosine phosphorylation of p52shc in T lymphocytes.
Burns, L. A., Karnitz, L. M., Sutor, S. L., & Abraham, R. T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46751-2 · Cited by 89
Sahota, S., Leo, R., Hamblin, T. J., & Stevenson, F. K. (1996) · Blood · doi:10.1182/blood.v87.2.746.bloodjournal872746 · Cited by 89
Smit, L., de Vries-Smits, A. M. M., Bos, J. L., & Borst, J. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31975-0 · Cited by 88
Soluble interleukin‐6 receptor as a prognostic factor in multiple myeloma
Pulkki, K., Pelliniemi, T., Rajamäki, A., Tienhaara, A., Laakso, M., & Lahtinen, R. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.d01-1470.x · Cited by 88
Urashima, M., Teoh, G., Chauhan, D., Hoshi, Y., Ogata, A., Treon, S. P., Schlossman, R. L., & Anderson, K. C. (1997) · Blood · doi:10.1182/blood.v90.1.279 · Cited by 88
Self-citationSeremetis, S. V., Inghirami, G., Ferrero, D., Newcomb, E. W., Knowles, D. M., Dotto, G. P., & Dalla‐Favera, R. (1989) · Science · doi:10.1126/science.2536954 · Cited by 87
Cytokine signal transduction and the JAK family of protein tyrosine kinases
Wilks, A. F., & Harpur, A. G. (1994) · BioEssays · doi:10.1002/bies.950160505 · Cited by 86
Deletion of the retinoblastoma gene in multiple myeloma.
Dao, D., Sawyer, J. R., Epstein, J., Hoover, R. G., Barlogie, B., & Tricot, G. J. K. (1994) · PubMed · Cited by 84
Karyotype in multiple myeloma and plasma cell leukaemia
Weh, H. J., Gutensohn, K., Selbach, J., Kruse, R., Wacker-Backhaus, G., Seeger, D. R., Fiedler, W., Fett, W., & HOSSFELD, D. K. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90071-m · Cited by 84
Interleukin-6 dependence of advanced malignant plasma cell dyscrasias
Zhang, X., Bataille, R., Widjenes, J., & Klein, B. (1992) · Cancer · doi:10.1002/1097-0142(19920315)69:6<1373::aid-cncr2820690612>3.0.co;2-1 · Cited by 83
FLACTIF, M., Zandecki, M., Laï, J. L., et al. (1995) · PubMed · Cited by 83
Kumar, G., Gupta, S., Wang, S., & Nel, A. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4436 · Cited by 80
TNF and IL‐6 are potent growth factors for OH‐2, a novel human myeloma cell line
Børset, M., Waage, A., Brekke, O., & Helseth, E. (1994) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1994.tb00176.x · Cited by 80
Soluble interleukin‐6 receptor (sIL‐6R), a new prognostic factor in multiple myeloma
Kyrtsonis, M., Dedoussis, G. V., Zervas, C., Perifanis, V., Baxevanis, C. N., Stamatelou, M., & Maniatis, A. G. (1996) · British Journal of Haematology · doi:10.1046/j.1365-2141.1996.4721018.x · Cited by 79
Portier, M., Zhang, X., Caron, E., Lu, Z., Bataille, R., & Klein, B. (1993) · Blood · doi:10.1182/blood.v81.11.3076.3076 · Cited by 79
Effects of interleukin-4 on the in vitro growth of human lymphoid and plasma cell neoplasms
Taylor, C., Grogan, T., & Salmon, S. (1990) · Blood · doi:10.1182/blood.v75.5.1114.1114 · Cited by 78
Ogata, A., Nishimoto, N., Shima, Y., Yoshizaki, K., & Kishimoto, T. (1994) · Blood · doi:10.1182/blood.v84.9.3040.3040 · Cited by 75
Phosphorylation of the TAL1 Oncoprotein by the Extracellular-Signal-Regulated Protein Kinase ERK1
Cheng, J., Cobb, M. H., & Baer, R. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.801 · Cited by 75
Lioubin, M. N., Myles, G. M., Carlberg, K., Bowtell, D. D. L., & Rohrschneider, L. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.5682 · Cited by 74
Apoptosis regulated by a death factor and its receptor: Fas ligand and Fas
Nagata, S. (1994) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1994.0107 · Cited by 73
Cited by
Raje, N., & Anderson, K. C. (2000) · Current Treatment Options in Oncology · doi:10.1007/s11864-000-0017-x · Cited by 2,163
Self-citationBowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
“Previous studies have established the critical role of IL6 in proliferation and survival of human multiple myeloma cells (Hallek et al., 1998; Kishimoto et al., 1994).”
BackgroundCatlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Iwakoshi, N. N., Lee, A.-H., Vallabhajosyula, P., Otipoby, K. L., Rajewsky, K., & Glimcher, L. H. (2003) · Nature Immunology · doi:10.1038/ni907 · Cited by 880
Hideshima, T., Chauhan, D., Shima, Y., Raje, N., Davies, F. E., Tai, Y.-T., Treon, S. P., Lin, B., Schlossman, R. L., Richardson, P., et al. (2000) · Blood · doi:10.1182/blood.v96.9.2943 · Cited by 875
Self-citation
Metadata
- Authors
- Hallek, M., Leif Bergsagel, P., & Anderson, K. C.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1998-01-01
- Volume
- 91
- Issue
- 1
- Pages
- 3-21
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1777794242
- Cited by
- 752
- References
- 265
- FWCI
- 36.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.